3834-17-1 Usage
Uses
Used in Scientific Research:
(5alpha)-3,3-difluoroandrostan-17-one is used as a research compound for studying the effects and mechanisms of androgens, particularly in the context of androgen receptor function and androgen-related diseases. Its unique chemical structure allows for a deeper understanding of how androgens interact with biological systems and contribute to various physiological processes.
Used in Hormone Replacement Therapy:
In the medical field, (5alpha)-3,3-difluoroandrostan-17-one is used as a potential therapeutic agent for hormone replacement therapy. Given its androgenic properties, it may be considered for the treatment of conditions related to androgen deficiency or imbalance.
Used in Treatment of Androgen-Related Disorders:
(5alpha)-3,3-difluoroandrostan-17-one is also being explored for its potential applications in the treatment of androgen-related disorders. Its ability to modulate androgen receptor function may provide new avenues for managing conditions such as androgen insensitivity syndrome or other androgen-related health issues.
Used in Pharmaceutical Development:
In the pharmaceutical industry, (5alpha)-3,3-difluoroandrostan-17-one serves as a key compound in the development of new drugs targeting androgen-related diseases. Its unique properties make it a promising candidate for the creation of novel therapeutics that can address a range of health concerns related to androgen function.
Check Digit Verification of cas no
The CAS Registry Mumber 3834-17-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,8,3 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3834-17:
(6*3)+(5*8)+(4*3)+(3*4)+(2*1)+(1*7)=91
91 % 10 = 1
So 3834-17-1 is a valid CAS Registry Number.
3834-17-1Relevant academic research and scientific papers
Sievaenen, Elina,Noponen, Virpi,Kral, Vladimir,Briza, Tomas,Kolehmainen, Erkki
, p. 392 - 397 (2008)
Two geminal difluorosteroids, 3,3-difluoro-5β-cholan-24-oic acid (1)and 3,3-difluoro-5α-androstan-17-one (2), have been prepared from corresponding ketosteroids with diethylaminosulphuitrifluoride (DAST) treatment in moderate yields. The structures of 1 a
